Imunon, Inc. (IMNN) Insider Trading Activity

NASDAQ$0.8932-0.01 (-1.11%)
Market Cap
$5.05M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
584 of 849
Rank in Industry
338 of 491

IMNN Insider Trading Activity

IMNN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$38,153
6
100

Related Transactions

Eylward SusanGeneral Counsel and Corp Sec
0
$0
6
$38,153
$-38,153

About Imunon, Inc.

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently in development for various cancer indications. Additionally, Imunon possesses two feasibility-stage platform technologies aimed at creating nucleic …

Insider Activity of Imunon, Inc.

Over the last 12 months, insiders at Imunon, Inc. have bought $0 and sold $38,153 worth of Imunon, Inc. stock.

On average, over the past 5 years, insiders at Imunon, Inc. have bought $61,741 and sold $38,153 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,000 shares for transaction amount of $29,480 was made by Braun Donald P (director) on 2024‑08‑20.

List of Insider Buy and Sell Transactions, Imunon, Inc.

2026-08-31SaleEylward SusanGeneral Counsel and Corp Sec
2,525
0.0463%
$1.56
$3,950
-21.47%
2026-08-17SaleEylward SusanGeneral Counsel and Corp Sec
2,449
0.0477%
$1.63
$3,993
-15.00%
2026-08-03SaleEylward SusanGeneral Counsel and Corp Sec
2,541
0.0501%
$1.57
$3,977
-10.76%
2026-07-20SaleEylward SusanGeneral Counsel and Corp Sec
2,150
0.0858%
$1.78
$3,830
-16.95%
2026-07-06SaleEylward SusanGeneral Counsel and Corp Sec
920
0.0346%
$1.88
$1,730
-22.73%
2026-06-29SaleEylward SusanGeneral Counsel and Corp Sec
11,800
0.4581%
$1.75
$20,674
-14.44%
2024-08-20PurchaseBraun Donald Pdirector
25,000
0.2412%
$1.18
$29,480
-28.23%
2024-08-15PurchaseTardugno Michael HExecutive Chairman of Board
25,000
0.2106%
$1.03
$25,750
-11.00%
2024-08-15PurchaseLindborg StacyPresident and CEO
25,000
0.2004%
$0.98
$24,500
-11.00%
2022-04-12PurchaseTardugno Michael HChairman, President and CEO
4,000
0.1156%
$3.53
$14,129
-53.88%
2022-04-08PurchaseFritz Frederick J.
5,000
0.1657%
$4.05
$20,250
-58.42%
2022-03-02PurchaseFritz Frederick J.
2,000
0.0767%
$4.69
$9,372
-58.95%
2021-10-07PurchaseFritz Frederick J.director
20,000
0.144%
$0.88
$17,600
-68.41%
2021-05-17PurchaseBraun Donald Pdirector
5,000
0.0438%
$1.07
$5,350
-24.55%
2020-02-28PurchaseMartinez Alberto R Jrdirector
5,000
0.0368%
$0.90
$4,500
0.00%
2019-11-20PurchaseMartinez Alberto R Jrdirector
6,000
0.0697%
$1.42
$8,520
-11.28%
2019-11-06PurchaseFritz Frederick J.director
10,000
0.1135%
$1.39
$13,876
-13.99%
2019-11-04PurchaseMartinez Alberto R Jrdirector
4,000
0.0527%
$1.61
$6,440
-24.54%
2019-08-02PurchaseFritz Frederick J.director
10,000
0.1415%
$1.73
$17,300
-9.77%
2019-07-25PurchaseMartinez Alberto R Jrdirector
6,000
0.0864%
$1.76
$10,560
-10.61%
Total: 147
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
LINK MAXdirector
380385
6.7788%
$342,346.50120
Tardugno Michael HExecutive Chairman of Board
353346
6.2969%
$318,011.40310
<0.0001%
Lindborg StacyPresident and CEO
264166
4.7077%
$237,749.4010
Martinez Alberto R Jrdirector
45000
0.8019%
$40,500.00260
<0.0001%
PACE GARY Wdirector
43356
0.7726%
$39,020.4030
Borys NicholasCMO
35687
0.636%
$32,118.3050
Moran Sean F.Chief Financial Officer
35000
0.6237%
$31,500.0010
Chow Pok Yu Augustinedirector
34542
0.6156%
$31,087.8010
Hooper Robert Wdirector
25687
0.4578%
$23,118.30150
Braun Donald Pdirector
25597
0.4562%
$23,037.3020
<0.0001%
DEASEY ANTHONY PEVP, CFO
17944
0.3198%
$16,149.6010
Hahne WilliamVP of Research & Development
15100
0.2691%
$13,590.0040
Tumminello Timothy JController & CAO
12800
0.2281%
$11,520.0010
Fritz Frederick J.
11766
0.2097%
$10,589.40220
<0.0001%
CHURCH JEFFREY WAYNECFO
7298
0.1301%
$6,568.2030
WEAVER GREGORY LCFO
0
0%
$041
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$6,974,678
45
-14.98%
$4.63M
$29,645,465
28
8.09%
$6.48M
$633,070
27
-5.89%
$2.04M
$63,749,694
24
-12.24%
$6.4M
$287,718
15
-41.45%
$5.68M

IMNN Institutional Investors: Active Positions

Increased Positions7+36.84%285,890+181.61%
Decreased Positions6-31.58%11,370-7.22%
New Positions3New266,888New
Sold Out Positions0Sold Out0Sold Out
Total Postitions20+5.26%431,941+174.39%

IMNN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Drw Securities, Llc$217.001.83%55,027+55,027New2025-09-30
Riverview Capital Advisers, Llc$136.001.15%34,364+33,466+3,726.73%2025-09-30
Vanguard Group Inc$92.000.78%23,301+8,696+59.54%2025-09-30
Geode Capital Management, Llc$78.000.66%19,812+8,720+78.61%2025-09-30
Ubs Group Ag$43.000.36%10,804+9,628+818.71%2025-09-30
Morgan Stanley$18.000.15%4,509+4,384+3,507.2%2025-09-30
Blackrock, Inc.$18.000.15%4,46400%2025-09-30
Wells Fargo & Company/Mn$13.000.11%3,400+193+6.02%2025-09-30
Sbi Securities Co., Ltd.$4.000.04%1,072-14,926-93.3%2025-09-30
Citigroup Inc$1.000.01%306-582-65.54%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.